The company, known for its robotic spine surgery system, has garnered a lot of attention recently from analysts. Here are six things to know:
1. There was short interest totaling 673,177 shares on Feb. 13, which dropped 23.5 percent from Jan. 30 when there were 880,391 shares.
2. The days-to-cover ratio is 9.3 days based on the average daily volume of 72,274 shares.
3. WallachBeth Capital lowered the company’s price target from $21 to $16 and gave it a “buy rating” on Feb. 23.
4. A separate report from a Needham & Company analyst downgraded Mazor from “buy” to “hold” on Feb. 19.
5. Mazor opened the day at $11.75, better than the 52-week low at 9.63 but much lower than the 32-week high of $25.
6. Mazor’s market cap is $247.4 million wit n average 50-day moving of $11.11.
More articles on orthopedic devices:
SI-BONE reaches 15k iFuse procedures—5 things to know
Globus Medical, Aurora Spine, NuVasive & more—22 key notes
Spine device company stock report: 5 key companies
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
